Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Bone Tissue

Explore clinical trials studying Neoplasms, Bone Tissue. Study availability and eligibility vary by location and protocol.

469 public trials 125 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Bone Tissue trial results

Not Yet Recruiting

A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma

NCT05590572

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +4 more
Locations
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Qilu Hospital of Shandong University Jinan, Shandong, China
  • Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
  • Department of Orthopaedic Surgery, Sixth People's Hospital, Shanghai Jiao Tong University, Shanghai, Shanghai Municipality, China
View Trial Details
Completed

A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma

NCT03006848

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +4 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • St Jude Children's Research Hospital Memphis, Tennessee, United States
  • Texas Children's Cancer Center Houston, Texas, United States
View Trial Details
Completed

Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)

NCT03213678

Conditions
Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, +82 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 127 locations
View Trial Details
Completed

Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)

NCT03213665

Conditions
Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Hodgkin Lymphoma, Ann Arbor Stage III Non-Hodgkin Lymphoma, +91 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 117 locations
View Trial Details
Completed

Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

NCT03526250

Conditions
Advanced Malignant Solid Neoplasm, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ependymoma, +81 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 117 locations
View Trial Details

Related conditions